Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · IEX Real-Time Price · USD
5.96
-0.31 (-4.94%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Solid Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Solid Biosciences stock have an average target of 16.6, with a low estimate of 5.00 and a high estimate of 40. The average target predicts an increase of 178.52% from the current stock price of 5.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SLDB stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 4 | 4 | 4 | 6 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 7 | 7 | 8 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +101.34% | Jun 24, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 | Buy | Reiterates | $20 | +235.57% | Jun 21, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $12 → $10 | Hold | Maintains | $12 → $10 | +67.79% | May 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +168.46% | May 20, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $18 | Buy | Maintains | $21 → $18 | +202.01% | May 16, 2024 |
Financial Forecast
Revenue This Year
1.24M
Revenue Next Year
2.03M
from 1.24M
Increased by 63.73%
EPS This Year
-2.77
from -4.83
EPS Next Year
-2.81
from -2.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.9M | 9.4M | 9.8M | 47.7M | 274.7M |
| Avg | 1.2M | 2.0M | 1.9M | 15.4M | 121.8M |
| Low | n/a | n/a | n/a | n/a | 25.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 656.9% | 385.4% | 2,394.5% | 1,679.5% |
| Avg | - | 63.7% | -5.7% | 707.7% | 689.1% |
| Low | - | - | - | - | 63.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.71 | -2.30 | -1.92 | -2.33 | -0.87 |
| Avg | -2.77 | -2.81 | -2.72 | -2.99 | -1.00 |
| Low | -2.89 | -3.56 | -3.59 | -3.58 | -1.11 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.